Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics

BACKGROUND: Significant intertumoral heterogeneity exists as antitumor treatment is introduced. Heterogeneous therapeutic responses are conventionally evaluated by imaging examinations based on Response Evaluation Criteria in Solid Tumors (RECIST); nevertheless, there are increasing recognitions tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Jiawei, Wu, Chenfei, Li, Junyan, Chen, Foping, He, Shiwei, He, Qingmei, Zhou, Guanqun, Ma, Jun, Sun, Ying, Wei, Denghui, Lin, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396864/
https://www.ncbi.nlm.nih.gov/pubmed/35996151
http://dx.doi.org/10.1186/s12916-022-02463-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396864/
https://www.ncbi.nlm.nih.gov/pubmed/35996151
http://dx.doi.org/10.1186/s12916-022-02463-5

Ejemplares similares